• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6 5.33% $4.35

CLARITY PHARMACEUTICALS LTD

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
CU6 - Media and Industry News
2 3
18:08 141 51K
18:08 Last post  at6568 Comments Created with Sketch.  141  Views Created with Sketch.  51K 
CU6 12:22 7 3.7K
12:22 Last post  Delbz Comments Created with Sketch.  7  Views Created with Sketch.  3.7K 
CU6 00:46 8 2.5K
TRENDING NEWS

Australian-listed companies chase the rainbow of the renewable energy market

NEWS
24 May 2024
00:46 Last post  easysell Comments Created with Sketch.  8  Views Created with Sketch.  2.5K 
CU6
Research/Valuation
5 6 7
22/05/24 411 128K
22/05/24 Last post  flotsam222 Comments Created with Sketch.  411  Views Created with Sketch.  128K 
CU6
CU6 - ASX Charts
6 7 8
21/05/24 457 137K
21/05/24 Last post  Vivo Comments Created with Sketch.  457  Views Created with Sketch.  137K 
CU6 20/05/24 73 22K
20/05/24 Last post  Steadfast Comments Created with Sketch.  73  Views Created with Sketch.  22K 
CU6 17/05/24 0 314
17/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  314 
CU6 17/05/24 0 294
17/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  294 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice - Rob Thomas
22 May 16:11
 
Cleansing Notice
17 May 13:32
 
Application for quotation of securities - CU6
17 May 13:28
 
Cleansing Notice
03 May 10:13
 
Application for quotation of securities - CU6
03 May 10:09
 
Clarity to Present at 3 World Leading Conferences
03 May 09:51
 
View More arrow Created with Sketch.
(20min delay)
Last
$4.35
Change
0.220(5.33%)
Mkt cap ! $1.352B
Open High Low Value Volume
$4.10 $4.35 $4.05 $7.494M 1.770M

Buyers (Bids)

No. Vol. Price($)
1 2555 $4.29
 

Sellers (Offers)

Price($) Vol. No.
$4.35 5589 4
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
$4.25
  Change
0.220 ( 3.26 %)
Open High Low Volume
$4.09 $4.31 $4.09 45313
Last updated 15.58pm 24/05/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.